V:NYSEVisa Inc. Analysis
Data as of 2026-08-22 - not real-time
$371.04
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
Visa Inc. trades at $371.04, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. The last 30 days have gained 6.3%. With RSI at 61.4 the momentum picture is approaching overbought, alongside a bearish MACD signal. Watch $355.48 as support and $373.97 as the nearer resistance level.
Multiples put this in overvalued territory: 31.6 times earnings against the sector's 16.8. Sell-side targets cluster 12.3% above the current quote. Revenue is growing at 14.4% on a 50.8% profit margin. The 0.72% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 19.3%, a beta of 0.30 and a maximum drawdown of 17.4%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
Multiples put this in overvalued territory: 31.6 times earnings against the sector's 16.8. Sell-side targets cluster 12.3% above the current quote. Revenue is growing at 14.4% on a 50.8% profit margin. The 0.72% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 19.3%, a beta of 0.30 and a maximum drawdown of 17.4%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
Top Market Events
Global payments technology company Visa NYSE:V reported in Q2 CY2026, with sales up 14.Visa stock trades in the mid-$360s in August 2026 as the payment giant reports double-digit revenueBrown Advisory, an investment management company, released its “Brown Advisory Global Leaders Strategy” for the...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 331.88
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 31.6 versus sector average of 16.8
- Trading above the 200-day average of 331.88
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 31.6 versus sector average of 16.8
- Analyst targets imply +12.3% versus the current price
- Profit margin of 50.8% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth14.40%
Profit Margin50.78%
P/E Ratio31.6
ROE61.19%
ROA19.11%
Debt/Equity67.82
P/B Ratio19.7
Op. Cash Flow$22.6B
Free Cash Flow$20.4B
Industry P/E16.8
Technical Analysis
TrendBullish
RSI61.4
Support$355.48
Resistance$373.97
MA 20$365.28
MA 50$352.75
MA 200$331.88
MACDBearish
VolumeStable
Fear & Greed Index94.41
Valuation
Fair Value$248.95
Target Price$416.61
Upside/Downside12.28%
GradeOvervalued
TypeGrowth
Dividend Yield0.72%
Risk Assessment
Beta0.30
Volatility19.31%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.